LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1311 | 3473 | 4961 | 0.7000 | 0.6608 |
MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1311 | 3650 | 4973 | 0.7339 | 0.7027 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1311 | 1189 | 4870 | 0.2441 | -0.0506 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1311 | 1329 | 4961 | 0.2679 | 0.0068 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1311 | 998 | 4973 | 0.2007 | -0.1325 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1311 | 1240 | 4870 | 0.2546 | -0.0293 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1311 | 1098 | 4961 | 0.2213 | -0.0885 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1311 | 1431 | 4973 | 0.2877 | 0.0463 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1311 | 2490 | 5128 | 0.4855 | 0.3852 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1311 | 2484 | 5100 | 0.4871 | 0.3853 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1311 | 2141 | 5010 | 0.4273 | 0.2884 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1311 | 913 | 4870 | 0.1875 | -0.1743 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1311 | 971 | 4961 | 0.1957 | -0.1450 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1311 | 813 | 4973 | 0.1635 | -0.2202 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1311 | 1262 | 5128 | 0.2461 | -0.0195 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1311 | 1148 | 5100 | 0.2251 | -0.0658 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1311 | 1277 | 5010 | 0.2549 | -0.0138 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1311 | 951 | 4870 | 0.1953 | -0.1563 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1311 | 983 | 4961 | 0.1981 | -0.1396 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1311 | 816 | 4973 | 0.1641 | -0.2188 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1311 | 954 | 5128 | 0.1860 | -0.1495 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1311 | 966 | 5100 | 0.1894 | -0.1446 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1311 | 861 | 5010 | 0.1718 | -0.1957 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1311 | 955 | 4870 | 0.1961 | -0.1544 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1311 | 789 | 4961 | 0.1590 | -0.2327 |